Mascagni Wealth Management, Inc. Bio N Tech Se Put Options Transaction History
Mascagni Wealth Management, Inc.
- $101 Billion
- Q1 2025
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding BNTX
# of Institutions
340Shares Held
40MCall Options Held
1.43MPut Options Held
1.54M-
Baillie Gifford & CO8.16MShares$923 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$482 Million1.71% of portfolio
-
Primecap Management CO Pasadena, CA4.05MShares$458 Million0.31% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$214 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$204 Million0.84% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $27.4B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...